Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2013
03/26/2013US8404238 huTNFR1 selective antagonists
03/26/2013US8404237 Antibodies to the NOTCH1 receptor
03/26/2013US8404236 Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
03/26/2013US8404235 Antagonists of IL-6 to raise albumin and/or lower CRP
03/26/2013US8404234 Fixed dosing of HER antibodies
03/26/2013US8404233 Neutralizing monoclonal antibody against human DLL4
03/26/2013CA2791109A1 Generation of binding molecules
03/26/2013CA2579141C Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
03/26/2013CA2395197C Acyl pseudodipeptides which carry a functionalised auxiliary arm
03/26/2013CA2262459C Gene involved in cadasil, method of diagnosis and therapeutic application
03/23/2013CA2811188A1 Vaccine therapy
03/21/2013WO2013040564A2 Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof
03/21/2013WO2013040478A2 Hyr1-derived compositions and methods of treatment using same
03/21/2013WO2013040472A2 Compositions and methods related to dna damage repair
03/21/2013WO2013040371A2 Targeting the tumor microenvironment using manipulated nkt cells
03/21/2013WO2013040254A2 Anti-c.difficile toxin antibodies and associated methods
03/21/2013WO2013040188A1 Anti-cd11a antibodies and uses thereof
03/21/2013WO2013040142A2 Bioinformatic processes for determination of peptide binding
03/21/2013WO2013040047A1 Biopolymer films and methods of making and using same
03/21/2013WO2013040040A1 Peptides mimicking hiv-1 viral epitopes in the v2 loop for the gp120 surface envelope glycoprotein
03/21/2013WO2013040015A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
03/21/2013WO2013039989A1 Particluate vaccine formulations
03/21/2013WO2013039954A1 Anti-gitr antibodies
03/21/2013WO2013039880A1 Biomarkers and therapeutic targets of hepatocellular cancer
03/21/2013WO2013039872A1 Compositions and methods for treating inflammatory bowel diseases
03/21/2013WO2013039792A1 Immunogens based on an hiv-1 gp120 v1v2 epitope
03/21/2013WO2013039621A2 Methods and systems for making microtablets for drug delivery
03/21/2013WO2013039471A1 Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases
03/21/2013WO2013039271A1 Brain-damage-induced frontal lobe dysfunction model animal and composition for alleviating frontal lobe dysfunction
03/21/2013WO2013039166A1 Method for measuring anti-wt1 antibody
03/21/2013WO2013039069A1 Novel recombinant bcg vaccine
03/21/2013WO2013038385A2 Escherichia coli vaccine combination
03/21/2013WO2013038185A1 Methods and compositions for raising an immune response to hiv
03/21/2013WO2013038156A1 Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficile
03/21/2013WO2013037961A1 Anti-her2 vaccine based upon aav derived multimeric structures
03/21/2013WO2013037889A2 Vaccine
03/21/2013WO2013037841A2 Chimeric non-integrating lentiviral genomes as innovative vaccines against hiv-1
03/21/2013WO2013037804A1 Method for monitoring cytotoxic t lymphocyte (ctl) responses by a delayed-type hypersensitivity reaction using defined ctl viral epitopes
03/21/2013WO2013037718A1 Method for increasing etec cs6 antigen presentation on cell surface and products obtainable thereof
03/21/2013WO2013037397A1 Vaccine for protection against etec induced diarrhea comprising dmlt.
03/21/2013WO2013011062A3 Antagonistic antibodies against oscar
03/21/2013WO2013009826A9 Conjugating amines
03/21/2013WO2012167028A9 Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition
03/21/2013WO2012166859A3 Modulation of sphingosine 1-phosphate metabolizing enzymes for the treatment of negative-strand rna virus infections
03/21/2013WO2012166743A3 Fusion proteins of ciliate granule lattice proteins, granular protein particles thereof, and uses therefor
03/21/2013WO2012166659A3 Anti-emr1 antibodies
03/21/2013WO2012163817A3 Immunogenic composition
03/21/2013WO2012162257A3 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
03/21/2013WO2012158932A3 REMOVAL OF α-GAL EPITOPES FROM THERAPEUTIC GLYCOPROTEINS FOR AVOIDING INTERACTION WITH THE ANTI-GAL ANTIBODY
03/21/2013WO2012154203A3 Filovirus fusion proteins and their uses
03/21/2013WO2012149405A3 Tolerogenic synthetic nanocarriers for regulating innate immune responses
03/21/2013WO2012134520A4 Regulation of immune response by colocynthin and/or its derivatives
03/21/2013WO2012114125A3 Treatment and prevention of malaria
03/21/2013WO2009155513A3 Immunoglobulins with reduced aggregation
03/21/2013US20130074201 Cancer-specific genetic rearrangements
03/21/2013US20130072881 Vaccine formulations
03/21/2013US20130072667 Use of rgm and its modulators
03/21/2013US20130072664 Human monoclonal antibody having fat-reducing effect
03/21/2013US20130072660 Identification and use of novopeptides for the treatment of cancer
03/21/2013US20130071483 VACCINE PRODUCED USING OPTIMIZED IMMOBILIZATION ANTIGEN cDNA OF CRYPTOCARYON IRRITANS AND PRODUCING METHOD AND USE THEREOF
03/21/2013US20130071434 Campylobacter Polypeptides and Methods of Use
03/21/2013US20130071433 Interferon-ß Production Modulating Listeria Strains and Methods for Using Same
03/21/2013US20130071432 Combination virotherapy for cancer
03/21/2013US20130071431 Method for Preserving Polypeptides Using A Sugar and Polyethyleneimine
03/21/2013US20130071429 Bunyavirus vaccine
03/21/2013US20130071428 Peptides, conjugates and method for increasing immunogenicity of a vaccine
03/21/2013US20130071424 Peptides mimicking hiv-1 viral epitopes in the v2 loop for the gp120 surface envelope glycoprotein
03/21/2013US20130071423 Combination vaccine for streptococcus
03/21/2013US20130071422 Adjuvanted vaccines for serogroup b meningococcus
03/21/2013US20130071421 Turkey viral hepatitis virus and uses thereof
03/21/2013US20130071420 Yeast-based vaccines as immunotherapy
03/21/2013US20130071419 Universal dengue virus sequences and methods of use
03/21/2013US20130071416 Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae
03/21/2013US20130071414 Engineered cd19-specific t lymphocytes that coexpress il-15 and an inducible caspase-9 based suicide gene for the treatment of b-cell malignancies
03/21/2013US20130071413 Targeted immune conjugates
03/21/2013US20130071411 Iap bir domain binding compounds
03/21/2013US20130071410 Human CGRP Receptor Binding Proteins
03/21/2013US20130071409 ICOS Critically Regulates the Expansion and Function of Inflammatory Human Th17 Cells
03/21/2013US20130071408 Methods for Diagnosis and Treatment of Non-Insulin Dependent Diabetes Mellitus
03/21/2013US20130071407 Methods for modulating hematopoiesis and vascular growth
03/21/2013US20130071406 Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments
03/21/2013US20130071405 Antibodies to pcsk9 and uses thereof
03/21/2013US20130071403 Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
03/21/2013US20130071402 Pharmacogenetic test anti-resorptive therapy-associated osteonecrosis of the jaw
03/21/2013US20130071400 LINGO binding molecules and Pharmaceutical Use Thereof
03/21/2013US20130071399 Immunogen and Antivenom Against Violin Spider Venom
03/21/2013US20130071398 Pharmaceutical composition for treating and/or preventing cancer
03/21/2013US20130071397 Inhibitors of vascular endothelial growth factor (vegf) receptors and methods of use thereof
03/21/2013US20130071396 Method of inhibiting coagulation activation with human anti-factor v antibodies and use thereof
03/21/2013US20130071394 Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and methods of use
03/21/2013US20130071393 Methods for increasing red blood cell levels and treating anemia using a combination of gdf traps and erythropoietin receptor activators
03/21/2013US20130071392 Small Heat Shock Proteins and Active Fragments Thereof as a Therapy for Inflammation and Ischemia
03/21/2013US20130071391 Methods of Treating Glucose Metabolism Disorders
03/21/2013US20130071389 Methods for treatment of inflammatory diseases
03/21/2013US20130071388 Method for treating psoriasis
03/21/2013US20130071386 Immunoglobulin Formulation and Method of Preparation Thereof
03/21/2013US20130071385 Monoclonal antibodies
03/21/2013US20130071384 Antibody formulations
03/21/2013US20130071383 Selective modification of proteins
03/21/2013US20130071382 Egfr mutations
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 1823